Jump Financial, LLC Aadi Bioscience, Inc. Transaction History

Jump Financial, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Oct 21, 2024	BUY	$6.85 - $13.0 $139,055 - $263,900	20,300 New	20,300 $146,000
Q1 2023 May 03, 2023	BUY	$6.85 - $13.0 $66,445 - $126,100	9,700 Added 91.51%	20,300 $146,000
Q4 2022 Feb 13, 2023	SELL	$11.99 - $14.5 $104,313 - $126,150	-8,700 Reduced 45.08%	10,600 $135,000
Q3 2022 Nov 07, 2022	BUY	$12.03 - $14.22 $232,179 - $274,446	19,300 New	19,300 $273,000

12.6M

23.8K

Ticker AADI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,016,800
Market Cap $48.3M
Description
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.